UnknownNot Applicable

Study on the Myocardial Protective Effect of Upper Limb Ischemic Preconditioning in Patients Undergoing Off-pump Coronary Artery Bypass Grafting

China66 participantsStarted 2017-11-01

Plain-language summary

The purpose of the study was to verify the myocardial protective effect of RIPC in patients undergoing OPCABG.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * serious changes in several coronary arteries that need to receive OPCABG * NHYA II-III * ASA II-III Exclusion Criteria: * LVEF\< 35% * acute myocardial infarction * multiple organ dysfunction

What they're measuring

ICU staying time

Timeframe: average of 1 year

Trial details

NCT IDNCT03340181

SponsorShanghai Zhongshan Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03-31

Contact for this trial

Ke-fang Guo, Phd

021-64041990 guo.kefang@zs-hospital.sh.cn

View on ClinicalTrials.gov More OPCABG trials